Express Scripts Buy Looks Healthy

The acquisition of eviCore is synergistic with the fundamental business model of controlling health-care costs.

Oct. 27, 2017 11:02 a.m. ET

Oct. 27, 2017 11:02 a.m. ET

Maxim Group

We would continue to be buyers of Express Scripts following its conference call on mixed third-quarter results.

Express Scripts (ticker: ESRX) provided additional detail on the pending acquisition of eviCore and on its previously announced enterprise value initiative. We view eviCore as synergistic with Express Scripts’ fundamental...